melanoma-2017-posters-accepted-abstracts

12 / 15

Volume 2, Issue 3 2017 Journal of Medical Oncology and Therapeutics Dermatologists & Melanoma 2017
August 31-September 01, 2017
Page 82
&
2nd Euro-Global Congress on
August 31-September 01, 2017 London, UK
12th Global Dermatologists Congress
Melanoma and Skin Diseases
Wnt-dependent regulation of Sox10 expression in melanoma development
Shakhova Olga, Rexhep Uka, Christian Britschgi, Claudia Matter, Anja Kraettli, Mitchell Levesque and Reinhard Dummer
University Hospital Zurich, Switzerland
Metastatic melanoma is the most aggressive skin cancer and despite tremendous efforts and substantial advances in clinical
treatment of melanoma patients within recent years, it remains a deadly disease. Melanoma tissue is often heterogeneous
and, in addition to melanocytes, contains cells of other neural crest lineages. The transcriptional factor Sox10 is one of the key
regulatory molecules of neural crest stem cells development and as we have previously demonstrated, Sox10 plays a crucial
role in the formation and maintenance of giant congenital melanocytic nevi and melanoma in vitro and in vivo. However,
the molecular mechanisms underlying Sox10-mediated melanoma development remain largely uncharacterized. To identify
interaction partners of Sox10, we have performed unbiased screen usingmass-spectrometry based proteomics. We demonstrate
here that the canonical Wnt signaling is involved in fine-tuning of Sox10 expression levels in a β-catenin-dependent manner.
Moreover, we show that Sox10 physically interacts with β -catenin and that interfering with Wnt signaling impairs melanoma
formation via deregulation of Sox10 expression.
J Med Oncl Ther 2017, 2:3